TScan Therapeutics had a revenue of 2.17M in the quarter ending Mar 31, 2025, with 226.47%. This bring the company's revenue in the last twelve months to 4.42M, Decreased 57.00%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.